2026 Switzerland Meeting | 17th September | Basel

“The Rise of GenAI in Clinical Practice: Implications for the Future of Healthcare Market Research”

Join Robert Dossin, Managing Director - Europe, Instar Research, and Uğur Yazgan, Vice President, Head of Global Marketing and Commercial Excellence Oncology, Menarini Stemline

Therapeutics, as they explore how the rapid adoption of GenAI by healthcare professionals is reshaping the future of healthcare market research.

Drawing on proprietary data from more than 11,000 HCPs collected over three years, this session will examine how GenAI is changing clinical practice and what these shifts mean for the future of insights and pharmaceutical strategy.

Registration is now open. Join us to explore this and many more forward-thinking presentations under this year's theme, Insights 2026 to 2036 - Looking to the Future.

Register here: https://www.ephmra.org/events/91